We simulated 60 million trials. Here's what we found.
Adaptive trials are not new, but what’s changing is our ability to quantify their value with precision. By combining rigorous statistical frameworks with large-scale simulation, we can now make more informed decisions before a single patient is enrolled.In an industry where every trial counts, that’s a powerful advantage.And as this analysis shows, when you let trials learn and adapt, the results speak for themselves.
